InvestorsHub Logo
Followers 3
Posts 101
Boards Moderated 0
Alias Born 03/14/2021

Re: Jen45 post# 136187

Sunday, 12/19/2021 12:54:32 PM

Sunday, December 19, 2021 12:54:32 PM

Post# of 200355
“Partnering with Enzolytics reinforces the value of our fully integrated, end-to-end business model, which is designed to meet the unique needs and goals of our biotech clients,” said John Rim, CEO of Samsung Biologics. “We look forward to providing comprehensive services and professional support for the manufacturing of this important class of Monoclonal Antibody therapeutics for the treatment of HIV and SARS-CoV-2, helping to accelerate the process of drug development to IND filing and bring these life-saving products to patients.”

How is that?